What injections can be given orally or via enteral feeding tubes?

6 November 2020This updated Medicines Q&A is a quick reference summary to different types of enteral feeding tubes, in relation to medication issues. Not all enteral feeding…

Safety in Lactation: Antimuscarinic drugs

5 November 2020These antimuscarinics are used as premedication, to dry secretions, and for intraoperative bradycardia. They are given as a single dose by injection, repeated if necessary…

Safety in Lactation: Mydriatics and cycloplegics

4 November 2020Mydriatics and cycloplegics have limited systemic absorption in the mother, and pose negligible risk to a breastfed infant, especially when used as a single dose…

Safety in Lactation: Gastrointestinal antispasmodics

20 October 2020Additional information relating to breastfeeding To be used in conjunction with individual drug entries for specific information and guidance. There is limited evidence for drugs…

Hypersalivation – what drug treatment options are available?

1 August 2018This Medicines Q&A is one of a series of five Q&A documents to address the drug treatment of hypersalivation (drooling or sialorrhoea). It gives a…
Search Articles

Medicine Compliance Aid Stability

genericWockhardt UK Ltd

Wockhardt UK Ltd
Tablets 600 micrograms
R2 · Red 2Drug is not suitable for CAs due to theoretical reasons that cannot be mitigated.
Atropine effloresces on exposure to dry air and is slowly affected by light.
6 November 2015

Lactation Safety Information

As GI antispasmodic

As GI antispasmodic
Propantheline; Mebeverine
No published evidence of safety
Low levels anticipated in milk due to the drug’s properties
Short-term use unlikely to affect lactation. However, long-term use may theoretically carries higher risk than other anticholinergics due to the drug’s properties. See summary for further information on anticholinergic affects
31 July 2020

For premedication and bradycardia

For premedication and bradycardia
Low levels anticipated in milk due to the drug's properties
No published evidence of safety
31 July 2020

For ophthalmic use

For ophthalmic use
Tropicamide as diagnostic, Homatropine or cyclopentolate for longer-term use
Short-term use as a diagnostic considered to pose negligible risk, although has very long (7 days) duration of action
Longer-term use has theoretical risks – see summary
31 July 2020